BCL2 and ovarian carcinoma: In conclusion, calycosin may operate as an anti‐growth and apoptosis‐inducing agent against ovarian cancer SKOV3 cells by activating caspases and Bcl‐2 family proteins and the p53 pathway making it a prospective therapeutic agent for the treatment of ovarian cancer.